In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Jago Holding AG

Division of Vectura Group PLC

Latest From Jago Holding AG

Somatogen's Pot O' Gold

For Somatogen and many others, the earnout potential in M&As not only extends the time frame they need to achieve certain milestones and/or sales goals, but allows them to receive higher purchase prices.

Biotech Models, Part I: Near-Term Strategies

As biotech valuations turn south, VCs are searching for financeable models for new companies. In Part I of a two-part article, we examine near-term models. The message: Choose distribution or research, but not both at the same time.
BioPharmaceutical Strategy
See All

Company Information

  • Industry
  • Pharmaceuticals
  • Therapeutic Areas
  • Non-Specific
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Europe
      • Western Europe
        • Switzerland
  • Parent & Subsidiaries
  • Vectura Group PLC
  • Senior Management
  • Jacques Gonella, PhD, CEO
    Peter F Burrell, CFO
    Andy Francis, VP, Bus. Dev.
    Robert Zimmer, MD, VP, R&D
  • Contact Info
  • Jago Holding AG
    Phone: (41) 441 614675555
    Eptingerstrasse 51
    Muttenz/Basel, CH-4132